Cargando...
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans
BACKGROUND: Erythropoietin (EPO) has been reported as a novel determinant of fibroblast growth factor 23 (FGF23) production; however, it is unknown whether FGF23 is stimulated by chronic exposure to EPO or by EPO administration in nonpolycystic chronic kidney disease (CKD) models. METHODS: We analyz...
Guardado en:
| Publicado en: | Nephrol Dial Transplant |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6888066/ https://ncbi.nlm.nih.gov/pubmed/30007314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy189 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|